ARIAD Pharmaceuticals, Inc. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/41564954-5d1f-4f10-b95f-b3edf79f1b13/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-231.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-485544 |
| FY 2014 | $-162.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-073392 |
| FY 2013 | $-274.2M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-080539 |
| FY 2012 | $-220.9M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-087814 |
| FY 2011 | $-123.6M | 2011-01-01 – 2011-12-31 | evidence 0001157523-12-001143 |
| FY 2010 | $85.2M | 2010-01-01 – 2010-12-31 | evidence 0001157523-12-001143 |
| FY 2009 | $-80.0M | 2009-01-01 – 2009-12-31 | evidence 0001157523-12-001143 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARIAD Pharmaceuticals, Inc. — all facts · Revenue · Operating Income